Company intelligence / Profile preview

Aidar Health

Columbia, Maryland, United Statesaidar.com ↗

Ownership: Private
Employees: ~12
Development stage: Commercial

Overview

Aidar Health’s flagship product, MouthLab, has received CE Mark approval and FDA clearance. It non-invasively measures over 10 vital parameters in under a minute. The device and its associated software are being clinically validated for early detection of decompensation events in chronic diseases such as heart failure and COPD as well as post-COVID conditions. The company has also developed AI-powered analytics to support real-time health insights and predictive care.

Therapeutic areas: PulmonologyPsychiatryCardiovascularInfectious Diseases
Modalities: DeviceDigital biomarkerSoftware
Industry: Physiological Monitoring

Partnerships

Johns Hopkins University (clinical pilots)University of MarylandTentHouse Health and Wellness (pilot site)Pharmaceutical companies interviewed for customer discovery

Beyond the preview

Go deeper on Aidar Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aidar Health.

Explore the full profile